Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Joseph Barr

Joseph Barr OD, MS, FAAO

Emeritus Professor at The Ohio State University College of Optometry

Dr. Barr is an active Emeritus Professor at The Ohio State University College of Optometry. He received his OD and MS at Ohio State in 1977 and 1979. For three years he was manager of clinical and materials research for Dow Corning Ophthalmics in the early 1980s. From 1983 to 2007 at Ohio State he was Contact Lens Clinical Service Chief and then Clinical Services Director and later Associate Dean for clinical services and professional programs. During that time he was the Director of the NEI sponsored Collaborative Longitudinal Evaluation of Keratoconus study photography reading center, and was the PI on numerous FDA studies and IITs. He has trained over 20 M.S. students in cornea and contact lenses and has over 50 peer reviewed publications in cornea and contact lenses. During his tenure with Ohio State, Dr. Barr served for two decades as editor of Contact Lens Spectrum and was founding editor of the electronic newsletter Contact Lenses Today. From July 2007 through June 2014 Dr. Barr was with Bausch + Lomb, initially as Vice President for R&D Global Vision Care and later for clinical and medical affairs for pharmaceuticals & vision care.

Disclosures

Dr. Barr has recently received funding for research from Allergan, Paragon Vision Sciences, Bausch+Lomb, and Innovega and is a stock holder in Envision, SMM, and Tree House. He has consulted for Bausch+Lomb/Valeant, NovaBay, Allergan, and Alcon.